- Review
 
The Lack of Standardization and Pharmacological Effect Limits the Potential Clinical Usefulness of Phytosterols in Benign Prostatic Hyperplasia
- Mădălina-Georgiana Buț,
 - George Jîtcă,
 - Silvia Imre,
 - Camil Eugen Vari,
 - Bianca Eugenia Ősz,
 - Carmen-Maria Jîtcă and
 - Amelia Tero-Vescan
 
The prevalence of benign prostatic hyperplasia (BPH) markedly increases with age. Phytotherapeutic approaches have been developed over time owing to the adverse side effects of conventional medications such as 5-reductase inhibitors and α1-adre...

